{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:45:43Z","timestamp":1792593943368,"version":"4.5.0"},"reference-count":33,"publisher":"MyJove Corporation","issue":"222","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68370","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:00:25Z","timestamp":1756508425000},"source":"Crossref","is-referenced-by-count":0,"title":["Amplicon Sequencing using the Long-Read Sequencing Technologies"],"prefix":"10.3791","author":[{"given":"Morwasehla","family":"Modjadji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon Coenrad","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Loubser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janr\u00e9","family":"Steyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Maria","family":"Streicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Grobbelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin Mark","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref1","type":"book","article-title":"Tuberculosis report","volume-title":"Baltimore Health News","year":"2022","unstructured":"WHO. Tuberculosis report. Baltimore Health News (2022)."},{"key":"ref2","type":"book","article-title":"WHO Malaria Department report","volume-title":"Report 20-23","year":"2023","unstructured":"WHO. Report 20-23. WHO Malaria Department report. January 2023 (2023)."},{"key":"ref3","volume-title":"The End Strategy TB","year":"2015","unstructured":"WHO. The End Strategy TB. 53 (1), 1689-1699 (2015).","type":"book"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"e0063220","DOI":"10.1128\/JCM.00632-20","type":"journal-article","article-title":"Application of targeted nextgeneration sequencing assay on a portable sequencing platform for culturefree detection of drugresistant tuberculosis from clinical samples","volume":"58","author":"Cabibbe","year":"2020","unstructured":"Cabibbe, A. M. et al. Application of targeted nextgeneration sequencing assay on a portable sequencing platform for culturefree detection of drugresistant tuberculosis from clinical samples. J Clin Microbiol. 58 (10), e0063220 (2020).","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"2002338","DOI":"10.1183\/13993003.02338-2020","type":"journal-article","article-title":"Deep amplicon sequencing for culturefree prediction of susceptibility or resistance to 13 antituberculous drugs","volume":"57","author":"Jouet","year":"2021","unstructured":"Jouet, A. et al. Deep amplicon sequencing for culturefree prediction of susceptibility or resistance to 13 antituberculous drugs. Eur Respir J. 57 (3), 2002338 (2021).","journal-title":"Eur Respir J"},{"issue":"1","key":"ref6","first-page":"e0128723","type":"journal-article","article-title":"How well do routine molecular diagnostics detect Rifampin","volume":"57","author":"NG","year":"2019","unstructured":"NG, K.C.S. et al. How well do routine molecular diagnostics detect Rifampin? J Clin Microbiol. 57 (1), e0128723 (2019).","journal-title":"J Clin Microbiol"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"e0158219","DOI":"10.1128\/JCM.01582-19","type":"journal-article","article-title":"Advances in molecular diagnosis of tuberculosis","volume":"58","author":"MacLean","year":"2020","unstructured":"MacLean, E., Kohli, M., Weber, S. F., Suresh, A. Advances in molecular diagnosis of tuberculosis. J Clin Microbiol. 58 (10), e0158219 (2020).","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref8","first-page":"42","type":"journal-article","article-title":"Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing","volume":"14","author":"Sibandze","year":"2022","unstructured":"Sibandze, D. B. et al. Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 14 (1), 42 (2022).","journal-title":"Genome Med"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/1471-2334-13-352","type":"journal-article","article-title":"Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drugresistant tuberculosis in South Africa","volume":"13","author":"Shah","year":"2013","unstructured":"Shah, M., Chihota, V., Coetzee, G., Churchyard, G., Dorman, S. E. Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drugresistant tuberculosis in South Africa. BMC Infect. Dis. 13 (1), 352 (2013).","journal-title":"BMC Infect. Dis"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.humimm.2021.02.012","type":"journal-article","article-title":"Nextgeneration sequencing technologies: An overview","volume":"82","author":"Hu","year":"2021","unstructured":"Hu, T., Chitnis, N., Monos, D., Dinh, A. Nextgeneration sequencing technologies: An overview. Hum Immunol. 82 (10), 801-811 (2021).","journal-title":"Hum Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3457806","DOI":"10.1155\/2022\/3457806","type":"journal-article","article-title":"A comprehensive review of performance of nextgeneration sequencing platforms","volume":"2022","author":"Pervez","year":"2022","unstructured":"Pervez, M. T. et al. A comprehensive review of performance of nextgeneration sequencing platforms. Biomed Res Int. 2022, 3457806 (2022).","journal-title":"Biomed Res Int"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/clinchem\/hvaa092","type":"journal-article","article-title":"Targetedsequencing workflows for comprehensive drug resistance profiling of Mycobacterium tuberculosis cultures using two commercial sequencing platforms: Comparison of analytical and diagnostic performance, turnaround time, and cost","volume":"66","author":"Tafess","year":"2020","unstructured":"Tafess, K. et al. Targetedsequencing workflows for comprehensive drug resistance profiling of Mycobacterium tuberculosis cultures using two commercial sequencing platforms: Comparison of analytical and diagnostic performance, turnaround time, and cost. Clin Chem. 66 (6), 809-820 (2020).","journal-title":"Clin Chem"},{"key":"ref13","type":"book","article-title":"Use of targeted nextgeneration sequencing to detect drugresistant tuberculosis","volume-title":"WHO rapid communication","year":"2023","unstructured":"WHO. Use of targeted nextgeneration sequencing to detect drugresistant tuberculosis. WHO rapid communication. https:\/\/www.who.int\/publications\/i\/item\/9789240076372 (2023)."},{"issue":"6","key":"ref14","first-page":"1408","type":"journal-article","article-title":"Impact of wholegenome sequencing of Mycobacterium tuberculosis on treatment outcomes for MDRTB\/XDRTB: A systematic review","volume":"15","author":"Hazra","year":"2023","unstructured":"Hazra, D. et al. Impact of wholegenome sequencing of Mycobacterium tuberculosis on treatment outcomes for MDRTB\/XDRTB: A systematic review. Pharmaceutics. 15 (6), 1408 (2023).","journal-title":"Pharmaceutics"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1128\/JCM.00298-17","type":"journal-article","article-title":"Comprehensive wholegenome sequencing and reporting of drug resistance profiles on clinical cases of Mycobacterium tuberculosis in New York State","volume":"55","author":"Shea","year":"2017","unstructured":"Shea, J. et al. Comprehensive wholegenome sequencing and reporting of drug resistance profiles on clinical cases of Mycobacterium tuberculosis in New York State. J Clin Microbiol. 55 (6), 1871-1882 (2017).","journal-title":"J Clin Microbiol"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","type":"journal-article","article-title":"Whole genome sequencing of Mycobacterium tuberculosis: Current standards and open issues","volume":"17","author":"Meehan","year":"2019","unstructured":"Meehan, C. J. et al. Whole genome sequencing of Mycobacterium tuberculosis: Current standards and open issues. Nat Rev Microbiol. 17 (10), 533-545 (2019).","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"ref17","first-page":"e000555","type":"journal-article","article-title":"Comprehensive and accurate genetic variant identification from contaminated and lowcoverage Mycobacterium tuberculosis whole genome sequencing data","volume":"7","author":"Heupink","year":"2021","unstructured":"Heupink, T. H., Verboven, L., Warren, R. M., Van Rie, A. Comprehensive and accurate genetic variant identification from contaminated and lowcoverage Mycobacterium tuberculosis whole genome sequencing data. Microb Genom. 7 (1), e000555 (2021).","journal-title":"Microb Genom"},{"issue":"2","key":"ref18","first-page":"120","type":"journal-article","article-title":"Interpretation of the third edition of WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis: Rapid diagnostics for tuberculosis detection","volume":"46","author":"Wang","year":"2024","unstructured":"Wang, X. et al. Interpretation of the third edition of WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis: Rapid diagnostics for tuberculosis detection. Chin J Antituberc. 46 (2), 120-130 (2024).","journal-title":"Chin J Antituberc"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"102051","DOI":"10.1016\/j.tube.2021.102051","type":"journal-article","article-title":"Targeted nextgeneration sequencing directly from sputum for comprehensive genetic information on drugresistant Mycobacterium tuberculosis","volume":"127","author":"Kambli","year":"2021","unstructured":"Kambli, P. et al. Targeted nextgeneration sequencing directly from sputum for comprehensive genetic information on drugresistant Mycobacterium tuberculosis. Tuberculosis. 127 (1), 102051 (2021).","journal-title":"Tuberculosis"},{"key":"ref20","type":"book","article-title":"Use of targeted nextgeneration sequencing to detect drugresistant tuberculosis","volume-title":"Rapid Communication","year":"2023","unstructured":"WHO. Use of targeted nextgeneration sequencing to detect drugresistant tuberculosis.Rapid Communication. 1-8 (2023)."},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.2147\/IDR.S381643","type":"journal-article","article-title":"Rapid molecular assays for the diagnosis of drugresistant tuberculosis","volume":"15","author":"Nandlal","year":"2022","unstructured":"Nandlal, L., Perumal, R., Naidoo, K. Rapid molecular assays for the diagnosis of drugresistant tuberculosis. Infect Drug Resist. 15 (1), 4971-4984 (2022).","journal-title":"Infect Drug Resist"},{"issue":"5","key":"ref22","first-page":"e0123422","type":"journal-article","article-title":"Nanopore sequencing for Mycobacterium tuberculosis: A critical review of the literature, new developments, and future opportunities","volume":"60","author":"Dippenaar","year":"2022","unstructured":"Dippenaar, A. et al. Nanopore sequencing for Mycobacterium tuberculosis: A critical review of the literature, new developments, and future opportunities. J Clin Microbiol. 60 (5), e0123422 (2022).","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13104-020-05287-9","type":"journal-article","article-title":"Rapid and economical drug resistance profiling with nanopore MinION for clinical specimens with low bacillary burden of Mycobacterium tuberculosis","volume":"13","author":"Chan","year":"2020","unstructured":"Chan, W. S. et al. Rapid and economical drug resistance profiling with nanopore MinION for clinical specimens with low bacillary burden of Mycobacterium tuberculosis. BMC Res Notes. 13 (1), 123 (2020).","journal-title":"BMC Res Notes"},{"issue":"4","key":"ref24","first-page":"2004784","type":"journal-article","article-title":"Rapid genomic first and secondline drug resistance prediction from clinical Mycobacterium tuberculosis specimens using DeeplexMycTB","volume":"57","author":"Feuerriegel","year":"2021","unstructured":"Feuerriegel, S. et al. Rapid genomic first and secondline drug resistance prediction from clinical Mycobacterium tuberculosis specimens using DeeplexMycTB. Eur Respir J. 57 (4), 2004784 (2021).","journal-title":"Eur Respir J"},{"key":"ref25","type":"book","article-title":"GenoScreen product brochure","volume-title":"Deeplex MycTB","year":"2023","unstructured":"GenoScreen. Deeplex MycTB. GenoScreen product brochure (2023)."},{"issue":"1","key":"ref26","first-page":"102194","type":"journal-article","article-title":"A practical approach to render tuberculosis samples safe for application of tuberculosis molecular bacterial load assay in clinical settings without a biosafety level 3 laboratory","volume":"138","author":"Mtafya","year":"2023","unstructured":"Mtafya, B. et al. A practical approach to render tuberculosis samples safe for application of tuberculosis molecular bacterial load assay in clinical settings without a biosafety level 3 laboratory. Tuberculosis. 138 (1), 102194 (2023).","journal-title":"Tuberculosis"},{"key":"ref27","type":"book","article-title":"Biosafety practices in mycobacteriology laboratory","volume-title":"Research Advances in Microbiology and Biotechnology","author":"Suganthi","year":"2023","unstructured":"Suganthi, P., Usharani, B., Venkateswari, R., Muthuraj, M. Biosafety practices in mycobacteriology laboratory. In: Research Advances in Microbiology and Biotechnology., Vol. 3, 1-39. B P International (a part of SCIENCEDOMAIN International), Chennai (2023)."},{"key":"ref28","type":"book","article-title":"consolidated guidelines on tuberculosis. Module 4: Treatment and care","volume-title":"WHO guideline","year":"2022","unstructured":"WHO. WHO consolidated guidelines on tuberculosis. Module 4: Treatment and care. WHO guideline (2022)."},{"issue":"181","key":"ref29","first-page":"e68147","type":"journal-article","article-title":"Matrixbased DNA extraction for targeted nextgeneration sequencing on decontaminated sputum samples","author":"Williams","year":"2025","unstructured":"Williams, J. et al. Matrixbased DNA extraction for targeted nextgeneration sequencing on decontaminated sputum samples. J Vis Exp. 181, e68147 (2025).","journal-title":"J Vis Exp"},{"issue":"2","key":"ref30","first-page":"e0245534","type":"journal-article","article-title":"Sequencing DNA with nanopores: Troubles and biases","volume":"16","author":"Delahaye","year":"2021","unstructured":"Delahaye, C., Nicolas, J. Sequencing DNA with nanopores: Troubles and biases. PLoS One. 16 (2), e0245534 (2021).","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"8845672","DOI":"10.1155\/2022\/7588033","type":"journal-article","article-title":"Rapid identification of drugresistant tuberculosis genes using direct PCR amplification and Oxford Nanopore Technology sequencing","volume":"2022","author":"Zhao","year":"2022","unstructured":"Zhao, K. et al. Rapid identification of drugresistant tuberculosis genes using direct PCR amplification and Oxford Nanopore Technology sequencing. Can J Infect Dis Med Microbiol. 2022, 8845672 (2022).","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"15076","DOI":"10.1038\/s41598-017-17705-3","type":"journal-article","article-title":"Culture and nextgeneration sequencingbased drug susceptibility testing unveil high levels of drugresistantTB in Djibouti: Results from the first national survey","volume":"7","author":"Tagliani","year":"2017","unstructured":"Tagliani, E. et al. Culture and nextgeneration sequencingbased drug susceptibility testing unveil high levels of drugresistantTB in Djibouti: Results from the first national survey. Sci Rep. 7 (1), 15076 (2017).","journal-title":"Sci Rep"},{"issue":"7","key":"ref33","first-page":"e0123421","type":"journal-article","article-title":"Assessing nanopore sequencing for clinical diagnostics: For Mycobacterium tuberculosis","volume":"59","author":"Smith","year":"2021","unstructured":"Smith, C., Halse, T. A., Shea, J., Modestil, H., Fowler, R. C. Assessing nanopore sequencing for clinical diagnostics: For Mycobacterium tuberculosis. J Clin Microbiol. 59 (7), e0123421 (2021).","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68370\/amplicon-sequencing-using-the-long-read-sequencing-technologies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:35:47Z","timestamp":1792593347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68370\/amplicon-sequencing-using-the-long-read-sequencing-technologies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":33,"journal-issue":{"issue":"222","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68370","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}